scorecardresearch
CDSCO approves extension of Covaxin's shelf life to up to 12 months

CDSCO approves extension of Covaxin's shelf life to up to 12 months

This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO," Bharat Biotech said in a tweet.

CDSCO approves extension of Covaxin's shelf life to up to 12 month (Photo: Reuters) CDSCO approves extension of Covaxin's shelf life to up to 12 month (Photo: Reuters)

Vaccine maker Bharat Biotech on Wednesday said the Central Drugs Standard Control Organisation (CDSCO) has approved the extension of shelf life of its COVID-19 vaccine Covaxin up to 12 months from the date of manufacture.

"The CDSCO has approved the extension of shelf life of Covaxin up to 12 months, from the date of manufacture. This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO," Bharat Biotech said in a tweet.

The shelf life extension has been communicated to "our stakeholders," it added.

Also Read: WHO grants emergency use listing to Bharat Biotech's Covaxin

Also Read: WHO panel likely to decide on Covaxin EUL today; here’s what you need to know

Published on: Nov 03, 2021, 6:43 PM IST
Posted by: Tarab Zaidi, Nov 03, 2021, 6:38 PM IST